Ani Pharmaceuticals reported $186.06M in Loan Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Aerie Pharmaceuticals AERI:US $ 228.19M 6.17M
Ani Pharmaceuticals ANIP:US $ 186.06M 3.46M
Aurora Cannabis Inc ACB:CN 363.25M 4.63M
Canopy Growth Corp WEED:CN C$ 1.52B 120.47M
Depomed DEPO:US $ 66.41M 0.34M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Emergent Biosolutions EBS:US $ 817.3M 7.9M
Endo International Ordinary Shares ENDP:US $ 8070.77M 3.67M
Flexion Therapeutics FLXN:US $ 250.5M 30.48M
Hikma Pharmaceutical HIK:LN 751M 13M
Knight Therapeutics Inc GUD:CN C$ 2.72M 176K
Lannett LCI:US $ 596.98M 6.29M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NVS:US $ 24715M 1776M
Omeros OMER:US $ 313.02M 433K
Perrigo Ordinary Shares PRGO:US $ 2920.9M 4.9M
Teva Pharmaceutical TEVA:IT 21.04B 565M
Teva Pharmaceutical Industries TEVA:US $ 21037M 565M